Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140019/S014

i-F ACTOR Peptide Enhanced Graft Substitute

Cerapedics, LLC · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONP140019/S014

What did the FDA decide?

The supplied record describes P140019/S014, a 30-Day Notice for Cerapedics, LLC under product code NOX, device category 'Filler, bone void, synthetic peptide.' The notice states changes to P-15 manufacturing at Bachem Americas attributed to 'equipment technological advancements and to improve process efficiency,' plus a series of minor or administrative specification changes. The supplement reason is listed as a process change affecting manufacturer, sterilizer, packager or supplier.

The identifier ties this filing to the existing P140019 PMA as a supplement, not a new approval of the whole system. The source gives no details on which specifications changed, what equipment was involved, or what validation supported the change. The stated purpose of improving process efficiency is the applicant's description of intent and does not by itself establish safety or clinical effectiveness.

Readers should note what is absent: the record does not describe the original P-15 scope, the peptide's role, or any performance data. Regulatory status here is procedural, and the decision code 'OK30' appears without further explanation in the supplied fields.

FDA approval order statement

changes to the P-15 manufacturing occurring at Bachem Americas due to equipment technological advancements and to improve process efficiency , as well as a series of minor/administrative specifications changes
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Sep 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140019/S014
Regulatory pathway
PMA supplement
Product code
NOX
Decision code
OK30
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, bone void, synthetic peptide.

Product code
NOX
FDA device class
3

For the original device and its historical approval scope, see PMA P140019. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140019 · Original PMA

    I-FACTOR PEPTIDE ENHANCED BONE GRAFT

  2. P140019/S014 received

    Application receipt date recorded by FDA.

  3. P140019/S014 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140019. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140019

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, LLCPMA approvalNov 3, 2015FDA

Explore the linked device profile

Other records with product code NOX

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, Inc.PMA supplementSep 16, 2026FDA
Cerapedics, Inc.PMA approvalJun 18, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cerapedics, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11025 Dover St., Suite 1600, Westminster, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records